Clinical trial
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of…
NCT00288509 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00288509 |
|---|---|
| Title | Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia |
| Official title | A Phase III, Prospective, Multicenter, Open-label Extension Study to Assess the Longer Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Cervical Dystonia |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Dystonia |
| Intervention type | Biological |
| Interventions | Botulinum toxin type A |
| Enrollment | 108 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Feb 8, 2006 |
| Last update posted | Sep 28, 2022 |
| Countries | Russia, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: